抗体催化可卡因的降解
1Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY 10032.
概括
人工酶被创造来分解可卡因,通过减少可卡因的奖励作用,为可卡因依赖提供了潜在的新治疗方法. 这种免疫战略的目标是可卡因.
科学领域:
- 生物化学 生物化学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 可卡因依赖是一个重要的公共卫生问题,治疗选择有限.
- 目前对物质使用障碍的治疗方法通常集中在行为干预或药物上,有效性各不相同.
- 了解可卡因的代谢途径对于开发有针对性的治疗策略至关重要.
研究的目的:
- 开发能够降解可卡因的新型催化抗体.
- 研究通过这些抗体被动免疫的潜力,作为可卡因依赖的治疗方法.
- 通过工程抗体评估可卡因水解的疗效.
主要方法:
- 用可卡因的酸单过渡状态类似物免疫动物,以产生单克隆抗体.
- 使用放射性标记可卡因进行测试的开发,以识别和量化抗体介导可卡因降解.
- 描述由抗体催化可卡因的水解产物.
主要成果:
- 成功生成了能够催化可卡因醇基组的水解的单克隆抗体.
- 该试验确定了将可卡因降解为生态甲基和酸的活性酶.
- 这些水解产品缺乏与可卡因相关的刺激活性.
结论:
- 催化抗体可以有效地降解可卡因,使其无活性.
- 用这些可卡因水解抗体进行被动免疫,为治疗可卡因依赖症提供了一个有前途的治疗策略.
- 这种方法可以减轻可卡因的强化作用,有助于成治疗.
相关概念视频
Regulated Protein Degradation
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
GPCR Desensitization
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
Antidotes
Antidotes are medicinal substances used to counteract the harmful effects of toxins or drugs in the body. They function in various ways, each uniquely designed to combat specific toxic compounds.
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
Desensitization and Tachyphylaxis
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...
Several...
Adrenergic Agonists: Indirect-Acting Agents
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...


